Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

170 8 Interleukin-10 in Cancer Immunity
of monocytes to dendritic cells but promotes
their maturation to macrophages.
Eur J Immunol 1998; 28: 359±
69.
41 Banchereau J, Steinman RM. Dendritic
cells and the control of immunity.
Nature 1998; 392: 245±52.
42 de Waal Malefyt R, Abrams J, Bennett
B, Figdor CG, de Vries JE. Interleukin
10 (IL-10) inhibits cytokine
synthesis by human monocytes: an
autoregulatory role of IL-10 produced
by monocytes. J Exp Med 1991; 174:
1209±20.
43 Fiorentino DF, Zlotnik A, Mosmann
TR, Howard M, O'Garra A. IL-
10 inhibits cytokine production by activated
macrophages. J Immunol 1991;
147: 3815±22.
44 Jenkins JK, Malyak M, Arend WP.
The effects of interleukin-10 on interleukin-1
receptor antagonist and interleukin-1
b production in human monocytes
and neutrophils. Lymphokine Cytokine
Res 1994; 13: 47±54.
45 Joyce DA, Gibbons DP, Green P,
Steer JH, Feldmann M, Brennan FM.
Two inhibitors of pro-inflammatory cytokine
release, interleukin-10 and interleukin-4,
have contrasting effects on release
of soluble p75 tumor necrosis factor
receptor by cultured monocytes. Eur
J Immunol 1994; 24: 2699±705.
46 Hart PH, Hunt EK, Bonder CS, Watson
CJ, Finlay-Jones JJ. Regulation of
surface and soluble TNF receptor expression
on human monocytes and synovial
fluid macrophages by IL-4 and
IL-10. J Immunol 1996; 157: 3672±80.
47 de Waal Malefyt R, Haanen J, Spits
H, et al. Interleukin 10 (IL-10) and viral
IL-10 strongly reduce antigen-specific
human T cell proliferation by diminishing
the antigen-presenting capacity of
monocytes via downregulation of class
II major histocompatibility complex expression.
J Exp Med 1991; 174: 915±24.
48 Creery WD, Diaz-Mitoma F, Filion L,
Kumar A. Differential modulation of
B7±1 and B7±2 isoform expression on
human monocytes by cytokines which
influence the development of T helper
cell phenotype. Eur J Immunol 1996;
26: 1273±7.
49 Willems F, Marchant A, Delville JP,
et al. Interleukin-10 inhibits B7 and intercellular
adhesion molecule-1 expression
on human monocytes. Eur J Immunol
1994; 24: 1007±9.
50 D'Andrea A, Aste-Amezaga M, Valiante
NM, Ma X, Kubin M, Trinchieri
G. Interleukin 10 (IL-10) inhibits
human lymphocyte interferon g-production
by suppressing natural killer
cell stimulatory factor/IL-12 synthesis
in accessory cells. J Exp Med 1993; 178:
1041±8.
51 Buchwald UK, Geerdes-Fenge HF,
Vockler J, Ziege S, Lode H. Interleukin-10:
effects on phagocytosis and adhesion
molecule expression of granulocytes
and monocytes in a comparison
with prednisolone. Eur J Med Res 1999;
4: 85±94.
52 te Velde AA, de Waal Malefijt R,
Huijbens RJ, de Vries JE, Figdor CG.
IL-10 stimulates monocyte Fc g R surface
expression and cytotoxic activity.
Distinct regulation of antibody-dependent
cellular cytotoxicity by IFN-g, IL-4,
and IL-10. J Immunol 1992; 149: 4048±
52.
53 Spittler A, Schiller C,Willheim M,
Tempfer C,Winkler S, Boltz-Nitulescu
G. IL-10 augments CD23 expression
on U937 cells and down-regulates
IL-4-driven CD23 expression on cultured
human blood monocytes: effects
of IL-10 and other cytokines on cell phenotype
and phagocytosis. Immunology
1995; 85: 311±7.
54 Calzada-Wack JC, Frankenberger M,
Ziegler-Heitbrock HW. Interleukin-
10 drives human monocytes to CD16
positive macrophages. J Inflamm 1996;
46: 78±85.
55 Ritter M, Buechler C, Langmann T,
Orso E, Klucken J, Schmitz G. The
scavenger receptor CD163: regulation,
promoter structure and genomic organization.
Pathobiology 1999; 67: 257±61.
56 Roilides E, Anastasiou-Katsiardani
A, Dimitriadou-Georgiadou A, et al.
Suppressive effects of interleukin-10 on
human mononuclear phagocyte function
against Candida albicans and Staphylococcus
aureus. J Infect Dis 1998;
178: 1734±42.